Quince Therapeutics Inc. (QNCX)
NASDAQ: QNCX
· Real-Time Price · USD
1.61
0.01 (0.31%)
At close: Sep 05, 2025, 3:58 PM
1.59
-1.24%
After-hours: Sep 05, 2025, 07:12 PM EDT
0.31% (1D)
| Bid | 1.57 |
| Market Cap | 86.48M |
| Revenue (ttm) | 168K |
| Net Income (ttm) | -49.03M |
| EPS (ttm) | -1.09 |
| PE Ratio (ttm) | -1.48 |
| Forward PE | -2.27 |
| Analyst | Buy |
| Ask | 1.66 |
| Volume | 86,485 |
| Avg. Volume (20D) | 240,869 |
| Open | 1.60 |
| Previous Close | 1.60 |
| Day's Range | 1.57 - 1.64 |
| 52-Week Range | 0.68 - 2.45 |
| Beta | 1.02 |
About QNCX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNCX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QNCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+19.17%
Quince Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
9 months ago
+19.5%
Quince Therapeutics shares are trading higher after the company reported a year-over-year increase in Q3 EPS results.
